The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study.
Xiao-Pu HeXiudi HanYan Li LiChunxiao ZhangXiqian XingPublished in: BMC infectious diseases (2020)
Early NAI therapy is associated with better outcomes in FluA-p patients. Improved education and training of clinicians on the guidelines of influenza are needed.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- prognostic factors
- peritoneal dialysis
- stem cells
- type diabetes
- intensive care unit
- metabolic syndrome
- mesenchymal stem cells
- patient reported outcomes
- acute respiratory distress syndrome
- patient reported
- extracorporeal membrane oxygenation